Patents by Inventor Ravi Garigipati

Ravi Garigipati has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DIBENZYL AMINE COMPOUNDS AND DERIVATIVES
    Publication number: 20090239865
    Abstract: Dibenzyl amine compounds and derivatives, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
    Type: Application
    Filed: November 21, 2005
    Publication date: September 24, 2009
    Inventors: George Chang, Mary Didiuk, Peter Dorff, Ravi Garigipati, Wenhua Jiao, Bruce Lefker, David Perry, Roger Ruggeri, Toby Underwood
  • Quinoline and quinoxaline compounds
    Publication number: 20060122224
    Abstract: Quinoline and quinoxaline compounds, pharmaceutical compositions containing such compounds and the use of such compounds to elevate certain plasma lipid levels, including high density lipoprotein-cholesterol and to lower certain other plasma lipid levels, such as LDL-cholesterol and triglycerides and accordingly to treat diseases which are exacerbated by low levels of HDL cholesterol and/or high levels of LDL-cholesterol and triglycerides, such as atherosclerosis and cardiovascular diseases in some mammals, including humans.
    Type: Application
    Filed: December 15, 2005
    Publication date: June 8, 2006
    Inventors: Bruce Bechle, George Chang, Mary Diduik, Jari Finneman, Ravi Garigipati, Rayn Kelley, David Perry, Michael Pollastri, Roger Ruggeri
  • Modulators of chemokine receptor activity
    Publication number: 20050234090
    Abstract: Chemokine receptor antagonists, in particular, bicyclic diamine compounds of Formula (I) that act as antagonists of chemokine CCR2 and CCR3 receptors including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation are described herein.
    Type: Application
    Filed: November 15, 2004
    Publication date: October 20, 2005
    Inventors: Roberto Colon-Cruz, Mary Didiuk, Erin Duffy, Ravi Garigipati, Wan Lau, Wayne McDonald
  • 5-HT receptor ligands and uses thereof
    Publication number: 20050090503
    Abstract: Compounds of Formula (IA) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2 receptors in animals are described herein.
    Type: Application
    Filed: August 19, 2004
    Publication date: April 28, 2005
    Inventors: Phoebe Chiang, William Novomisle, Willard Welch, Angel Guzman-Perez, Paul DaSilva-Jardine, Ravi Garigipati, Kevin Liu
  • 5-HT receptor ligands and uses thereof
    Publication number: 20050020604
    Abstract: Compounds of Formula (IA) that act as 5-HT receptor ligands and their uses in the treatment of diseases linked to the activation of 5-HT2 receptors in animals are described herein.
    Type: Application
    Filed: August 19, 2004
    Publication date: January 27, 2005
    Inventors: Phoebe Chiang, William Novomisle, Willard Welch, Angel Guzman-Perez, Paul DaSilva-Jardine, Ravi Garigipati, Kevin Liu
  • Modulators of chemokine receptor activity
    Patent number: 6821964
    Abstract: Chemokine receptor antagonists, in particular, bicyclic diamine compounds of Formula (I) that act as antagonists of chemokine CCR2 and CCR3 receptors including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation are described herein.
    Type: Grant
    Filed: March 6, 2002
    Date of Patent: November 23, 2004
    Assignee: Pfizer Inc
    Inventors: Roberto Colon-Cruz, Mary T. Didiuk, Erin M. Duffy, Ravi Garigipati, Wan F. Lau, Wayne S. McDonald
  • Modulators of chemokine receptor activity
    Publication number: 20030008893
    Abstract: Chemokine receptor antagonists, in particular, bicyclic diamine compounds of Formula (I) that act as antagonists of chemokine CCR2 and CCR3 receptors including pharmaceutical compositions and uses thereof to treat or prevent diseases associated with monocyte accumulation, lymphocyte accumulation or leucocyte accumulation are described herein.
    Type: Application
    Filed: March 6, 2002
    Publication date: January 9, 2003
    Inventors: Roberto Colon-Cruz, Mary T. Didiuk, Erin M. Duffy, Ravi Garigipati, Wan F. Lau, Wayne S. McDonald
  • Cycloalkenyl substituted compounds
    Patent number: 6362193
    Abstract: Novel pyridyl or pyrimidinyl substituted cycloalkenyl compounds and compositions for use in therapy.
    Type: Grant
    Filed: April 7, 2000
    Date of Patent: March 26, 2002
    Assignee: SmithKline Beecham Corporation
    Inventors: Jerry L. Adams, Ravi Garigipati